Technivie (ombitasvir/paritaprevir/ritonavir) / AbbVie  >>  Phase 2
Welcome,         Profile    Billing    Logout  

8 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Technivie (ombitasvir/paritaprevir/ritonavir) / AbbVie
NCT01911845: An Open-label, Single Arm, Phase 2 Study to Evaluate ABT-450/r/ABT-267 and ABT-333 With Ribavirin (RBV) in Adults With Genotype 1 HCV Infection Taking Methadone or Buprenorphine

Checkmark CROI 2014
Mar 2014 - Mar 2014: CROI 2014
Completed
2
38
NA
ABT-450/r/ABT-267, ABT-450 also known as paritaprevir; ABT-267 also known as ombitasvir, ABT-333, dasabuvir, Ribavirin (RBV)
AbbVie
Chronic Hepatitis C Infection, Chronic Hepatitis C
12/13
09/14
NCT01672983: A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus Infection

Checkmark APASL 2014
Mar 2014 - Mar 2014: APASL 2014
Checkmark APASL 2014
Mar 2014 - Mar 2014: APASL 2014
Completed
2
110
NA
ABT-450/ritonavir, ABT-267, ABT-450 also known as paritaprevir, ABT-267 also known as ombitasvir, ritonavir also known as Norvir, ABT/450/r/ABT-267 (ABT-450 coformulated with ritonavir and ABT-267) also known as VIEKIRAX Combination Tablets
AbbVie (prior sponsor, Abbott)
Chronic Hepatitis C Infection
05/14
05/14
NCT01995071: A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)

Completed
2
89
NA
ABT-493, glecaprevir, ABT-530, pibrentasvir, ABT-450/r/ABT-267, ABT-333, ABT-267 also known as ombitasvir, ABT-450 also known as paritaprevir, ABT-333 also known as dasabuvir, Viekira PAK, Ribavirin (RBV)
AbbVie
Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis
06/15
06/15
NCT02493855 / 2014-001478-32: Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults

Completed
2
46
NA
Ombitasvir/ABT-450/Ritonavir, ABT-267/ABT-450/ritonavir, Dasabuvir, ABT-333, Ribavirin (RBV)
AbbVie
Chronic Hepatitis C, Hepatitis C (HCV), Hepatitis C Genotype 1a
04/16
12/16
NCT02356562: A Study of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection

Completed
2
29
NA
ombitasvir/paritaprevir/ritonavir and dasabuvir, ABT-450/r/ABT-267, Viekira Pak, paritaprevir also known as ABT-450, ombitasvir also known as ABT-267, dasabuvir also known as ABT-333, Sofosbuvir, Sovaldi, Ribavirin, RBV
AbbVie
Chronic Hepatitis C Infection
10/16
07/17
CORAL-I, NCT01782495 / 2012-004792-39: A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients

Checkmark AASLD 2014 - CORAL-I
Nov 2014 - Nov 2014: AASLD 2014 - CORAL-I
Checkmark Presented at AASLD 2014 for HCV infection
Nov 2014 - Nov 2014: Presented at AASLD 2014 for HCV infection
Checkmark AVHC 2014
More
Completed
2
129
NA
ombitasvir/paritaprevir/ritonavir and dasabuvir, Viekira Pak, paritaprevir also known as ABT-450, ombitasvir also known as ABT-267, dasabuvir also known as ABT-333, ombitasvir/paritaprevir/ritonavir, TECHNIVIE, ribavirin
AbbVie
Chronic Hepatitis C Infection
11/16
07/17
Quartz II/III, NCT02292719 / 2014-003147-35: A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection

Completed
2
70
NA
OBV/PTV/r, ABT-267 also known as ombitasvir, ABT-450 also known as paritaprevir, ritonavir (r) also known as Norvir, VIEKIRAX combination tablets, TECHNIVIE, Sofosbuvir, Sovaldi, Ribavirin (RBV)
AbbVie
Chronic Hepatitis C Virus Infection
07/17
07/17
2015-005004-28: Stratified Treatment OPtimisation for HCV-1 (STOPHCV-1)

Completed
2
408
Europe
Viekirax, Exviera (Dasabuvir), Harvoni, Ribavirin (film-coated 200mg), Ribavirin (hard capsule, 200mg), Ribavirin (film-coated, 400mg), Maviret, Film-coated tablet, , Viekirax, Exviera (Dasabuvir), Harvoni, Maviret
Imperial College London, NIHR Efficacy and Mechanism Evaluation Programme
Hepatitis C Infection (HCV) (genotype 1a/1b/4), Hepatitis C infection, Diseases [C] - Virus Diseases [C02]
 
 

Download Options